1.67 MONALEESA-7 and the Cost of Cancer Drugs with Dr. Stacie Dusetzina

Om avsnittet

This week we begin the episode by discussing MONALEESA-7 and why ribociclib has been shown to increase overall survival while palbociclib has not. We finish the episode with an in-depth interview with Dr. Stacie Dusetzina of Vanderbilt University on her work in pharmacoeconomics, specifically we discuss her work on the market value of cancer drugs. MONALEESA-7: doi.org/10.1056/NEJMoa1903765 Free drug samples are a marketing tool: doi.org/10.2105/AJPH.2007.114249 Back us on Patreon! www.patreon.com/plenarysession

Om avsnittet

Fler avsnitt

Pope has cancer; Phase 1 trials for AI; Can AI hack cancer trials__1

5.05 Measles in PA, Nature's editorial, and more

5.04 Jason Arday, Nathan Cofnas and the Decline of University Standards

5.03 - 5 red flags, Betting Markets, Covid Czar says lab origin

Season 5 Ep 2 - Anthony Fauci's Diary and Congressional Testimony

Reboot - I am back with Audio podcasts

Longevity Episode 2 - Nutrition science

Longevity Lecture series Introduction and Lecture 1

CABINET - trial - Cabozantinib for NET

CIA says lab leak, Fauci's pardon, NIH's meetings, RFK Jr's hearing & more!